Brian P. Hobbs
Statistics and Probability · 2011
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Statistics and Probability — 5 citations into it
Whom Brian P. Hobbs trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Brian P. Hobbs overall
Papers from Brian P. Hobbs's perspective
Ordered by how strongly the researchers Brian P. Hobbs trusts endorse each paper. Same corpus, a different order for every researcher.
- Bayesian clinical trials
- Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. (New England Journal of Medicine)
- Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. (Journal of Clinical Oncology)
- Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis. (Journal of the National Cancer Institute)
- Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. (Journal of the American Medical Association (JAMA))
- Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers (Journal of Neuroscience)
- Genome-wide cell-free DNA fragmentation in patients with cancer (Nature)
- Triple-negative breast cancer. (Clinical Journal of Oncology Nursing)
- Amiodarone versus sotalol for atrial fibrillation. (New England Journal of Medicine)
- Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. (New England Journal of Medicine)